| Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors B Sangro, G Mazzolini, J Ruiz, M Herraiz, J Quiroga, I Herrero, A Benito, ... Journal of clinical oncology 22 (8), 1389-1397, 2004 | 694 | 2004 |
| Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure J Fernandez-Seara, J Prieto, J Quiroga, JM Zozaya, MA Cobos, ... Gastroenterology 97 (5), 1304-1312, 1989 | 308 | 1989 |
| Prognostic factors and prevention of radioembolization‐induced liver disease B Gil‐Alzugaray, A Chopitea, M Iñarrairaegui, JI Bilbao, ... Hepatology 57 (3), 1078-1087, 2013 | 294 | 2013 |
| Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma B Sangro, JI Bilbao, J Boan, A Martinez-Cuesta, A Benito, J Rodriguez, ... International Journal of Radiation Oncology* Biology* Physics 66 (3), 792-800, 2006 | 279 | 2006 |
| Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma JI Herrero, B Sangro, J Quiroga, F Pardo, M Herraiz, JA Cienfuegos, ... Liver transplantation 7 (7), 631-636, 2001 | 248 | 2001 |
| A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis JF Lucena, JI Herrero, J Quiroga, B Sangro, J Garcia-Foncillas, ... Gastroenterology 124 (4), 1037-1042, 2003 | 240 | 2003 |
| Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. G Mazzolini, C Alfaro, B Sangro, E Feijoó, J Ruiz, A Benito-Boilos, ... American Society of Clinical Oncology, 2005 | 235 | 2005 |
| Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters J Quiroga, B Sangro, M Núñez, I Bilbao, J Longo, L Garcia-Villarreal, ... Hepatology 21 (4), 986-994, 1995 | 221 | 1995 |
| The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis R Rios, B Sangro, I Herrero, J Quiroga, J Prieto Official journal of the American College of Gastroenterology| ACG 100 (6 …, 2005 | 219 | 2005 |
| Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis I Castilla-Cortazar, M Garcia, B Muguerza, J Quiroga, R Perez, ... Gastroenterology 113 (5), 1682-1691, 1997 | 194 | 1997 |
| COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? MF Landecho, JR Yuste, E Gándara, P Sunsundegui, J Quiroga, ... Journal of Internal Medicine 289 (1), 116-120, 2021 | 184 | 2021 |
| Liver transplantation in patients with hepatocellular carcinoma across Milan criteria JI Herrero, B Sangro, F Pardo, J Quiroga, M Inarrairaegui, F Rotellar, ... Liver Transplantation 14 (3), 272-278, 2008 | 171 | 2008 |
| De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival JI Herrero, M Lorenzo, J Quiroga, B Sangro, F Pardo, F Rotellar, ... Liver Transplantation 11 (1), 89-97, 2005 | 171 | 2005 |
| Liver cytoprotection by prostaglandins J Quiroga, J Prieto Pharmacology & therapeutics 58 (1), 67-92, 1993 | 152 | 1993 |
| Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable … M Iñarrairaegui, F Pardo, JI Bilbao, F Rotellar, A Benito, D D'Avola, ... European Journal of Surgical Oncology (EJSO) 38 (7), 594-601, 2012 | 146 | 2012 |
| A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma B Sangro, G Mazzolini, M Ruiz, J Ruiz, J Quiroga, I Herrero, C Qian, ... Cancer gene therapy 17 (12), 837-843, 2010 | 144 | 2010 |
| Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial M Conchillo, RJ de Knegt, M Payeras, J Quiroga, B Sangro, JI Herrero, ... Journal of hepatology 43 (4), 630-636, 2005 | 139 | 2005 |
| Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy JI Herrero, JF Lucena, J Quiroga, B Sangro, F Pardo, F Rotellar, ... American Journal of Transplantation 3 (11), 1407-1412, 2003 | 130 | 2003 |
| Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil IJ Herrero, J Quiroga, B Sangro, M Girala, N Gómez-Manero, F Pardo, ... Liver Transplantation 5 (5), 414-420, 1999 | 122 | 1999 |
| Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance RG de la Garza, P Sarobe, J Merino, JJ Lasarte, D D'Avola, V Belsue, ... Liver Transplantation 19 (9), 937-944, 2013 | 113 | 2013 |
